Organogenesis Holdings (ORGO) Depreciation & Amortization (CF) (2018 - 2026)
Organogenesis Holdings has reported Depreciation & Amortization (CF) over the past 8 years, most recently at $4.1 million for Q4 2025.
- For Q4 2025, Depreciation & Amortization (CF) rose 12.48% year-over-year to $4.1 million; the TTM value through Dec 2025 reached $15.3 million, up 12.11%, while the annual FY2025 figure was $15.3 million, 12.11% up from the prior year.
- Depreciation & Amortization (CF) for Q4 2025 was $4.1 million at Organogenesis Holdings, up from $4.0 million in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $4.1 million in Q4 2025 and troughed at $1.0 million in Q1 2021.
- A 5-year average of $2.5 million and a median of $2.6 million in 2023 define the central range for Depreciation & Amortization (CF).
- Biggest five-year swings in Depreciation & Amortization (CF): decreased 24.83% in 2022 and later surged 100.0% in 2023.
- Year by year, Depreciation & Amortization (CF) stood at $1.8 million in 2021, then dropped by 14.51% to $1.5 million in 2022, then soared by 96.96% to $3.0 million in 2023, then increased by 21.23% to $3.6 million in 2024, then rose by 12.48% to $4.1 million in 2025.
- Business Quant data shows Depreciation & Amortization (CF) for ORGO at $4.1 million in Q4 2025, $4.0 million in Q3 2025, and $3.7 million in Q2 2025.